China | News | By BioSpectrum Bureau | 0 Comment | 12 Nov, 2012
Singapore: DKSH Business Unit Healthcare, a leading partner for healthcare companies seeking to grow their business in A...Read more
AusBiotech, Hong Kong firm to partner on investment events
China | News | By BioSpectrum Bureau | 0 Comment | 03 Oct, 2012
Singapore: Biotechnology industry group, AusBiotech and Beacon Events, organiser of the largest resource sector investor...Read more
Luqa Pharma is tailoring products for China
China | Influencers | By Piyusha Chatterjee | 3 Comment | 13 Feb, 2013
Mr Robert J Braithwaite, who came to China 15 years ago, was greatly influenced following his exposure to the dragon nat...Read more
WHO: Invest in local research to improve healthcare
China | News | By BioSpectrum Bureau | 0 Comment | 19 Aug, 2013
Singapore: WHO has urged countries to invest in local research in order to develop a system of universal health coverage...Read more
WHO: Bird flu is back in China
China | News | By BioSpectrum Bureau | 0 Comment | 02 Apr, 2013
Singapore: Three cases of human infection with influenza A (H7N9) has erupted in China, notified China Health and Family...Read more
WuXi to build its third cell therapy manufacturing facility
China | News | By BioSpectrum Bureau | 0 Comment | 13 Mar, 2015
Singapore: WuXi PharmaTech, provider of R&D capability and technology platform for pharmaceutical, biotechnology, an...Read more
China | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2012
Singapore: Agnitio, a leader in healthcare sector closed-loop marketing technology, continues to expand its global pres...Read more
PharmaNet/i3 wins award for oncology research
China | News | By BioSpectrum Bureau | 0 Comment | 08 Jun, 2012
Singapore: PharmaNet/i3, inVentiv Health's clinical segment, and a leading provider of clinical development services to ...Read more
Rongxiang Xu gets Golden Biatec award for regenerative science
China | Influencers | By BioSpectrum Bureau | 1 Comment | 22 Oct, 2013
Singapore: Dr Rongxiang Xu has been awarded the Golden Biatec 2013 international award by the Informal Economic Forum (I...Read more
China clears WuXi PharmaTech toxicology facility
China | News | By BioSpectrum Bureau | 0 Comment | 20 Aug, 2012
Singapore: Bioscience R&D outsourcing services company WuXi PharmaTech's toxicology facility in Suzhou has received ...Read more
QIAGEN gets SFDA's nod for careHPV Test
China | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2012
Singapore: QIAGEN announced that China's State Food and Drug Administration (SFDA) has approved QIAGEN's careHPV Test a...Read more
Stem cell therapy to treat liver cirrhosis
China | News | By BioSpectrum Bureau | 0 Comment | 05 Jul, 2012
Singapore: A study conducted by Beike Biotechnology Company in conjunction with physicians and researchers at two Chines...Read more
Lilly strengthens its foothold in China
China | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2012
Singapore, June 15, 2012: In support of its commitment to maximize growth opportunities in China, Eli Lilly has plans ...Read more
GlobalData: Osteoporosis market to be $8 bn
China | Analysis | By BioSpectrum Bureau | 0 Comment | 08 Mar, 2013
Singapore: According to GlobalData, the osteoporosis therapeutics market of the US, France, Germany, Italy, Spain, the ...Read more
Quintiles deepens investment in China
China | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2012
Singapore, June 18, 2012: CRO leading company, Quintiles plans to establish a Quintiles regional headquarters for China ...Read more
MedImmune and WuXi AppTec Announce Joint Venture to Develop Novel Biologic
China | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2012
Singapore: MedImmune, the global biologics arm of AstraZeneca, and WuXi AppTec, a leading research and development outs...Read more
Bal Seal expands in China to tap into growing medical industry
China | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2012
Singapore: Responding to predicted growth in China's medical industry, Bal Seal Engineering, a leading provider of cust...Read more
APAC ovarian cancer drug market to grow modestly'
China | Analysis | By BioSpectrum Bureau | 2 Comment | 30 Jan, 2015
Singapore: Asia Pacific (APAC) therapeutics market for ovarian cancer will undergo a modest rise in value, from $294.3 m...Read more